Literature DB >> 18806991

[Radical salvage prostatectomy : Treatment of local recurrence of prostate cancer after radiotherapy].

A Heidenreich1, R Semrau, D Thüer, D Pfister.   

Abstract

External beam radiation and low- and high-dose interstitial brachytherapy represent therapeutic alternatives to radical prostatectomy for organ-confined and locally advanced prostate cancer. Local recurrences are described in 5-35% of the patients depending on the individual risk profile, and most recurrences are detected due to asymptomatic PSA rise only. According to the most recent data, recurrences are defined by a PSA increase >2 ng/ml above the post-radiation nadir. Radical salvage prostatectomy represents a secondary local treatment with curative intent in patients with organ-confined recurrences. Preoperative risk factors predicting organ-confined disease are initial LDR brachytherapy, preoperative Gleason biopsy score < or =6, < or =50% biopsy cores involved with cancer, and a PSA doubling time >12 months. Metastatic disease should be ruled out preoperatively by skeletal scintigraphy, computed tomography, or magnetic resonance imaging of the abdomen and the small pelvis, and/or choline PET/CT. Functionality of the lower urinary tract is evaluated by urethrocystoscopy and urodynamics. The most appropriate candidates for radical salvage prostatectomy are patients with organ-confined disease or those with symptomatic local recurrences. In experienced hands, morbidity is low with a continence rate of 83-96% depending on the type of previous radiation therapy. Long-term oncological control can be achieved in more than 80% of the patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806991     DOI: 10.1007/s00120-008-1726-1

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  35 in total

1.  Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials.

Authors:  M Roach; J Lu; M V Pilepich; S O Asbell; M Mohiuddin; R Terry; D Grignon; M Mohuidden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-06-01       Impact factor: 7.038

2.  Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel.

Authors: 
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-03-15       Impact factor: 7.038

Review 3.  Local failure after definitive therapy for prostatic cancer.

Authors:  E L Robey; P F Schellhammer
Journal:  J Urol       Date:  1987-04       Impact factor: 7.450

Review 4.  Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel.

Authors:  J D Cox; M J Gallagher; E H Hammond; R S Kaplan; P F Schellhammer
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

5.  Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy.

Authors:  Andrew J Stephenson; Peter T Scardino; Fernando J Bianco; Christopher J DiBlasio; Paul A Fearn; James A Eastham
Journal:  J Urol       Date:  2004-12       Impact factor: 7.450

6.  Chemical disease-free survival in localized carcinoma of prostate treated with external beam irradiation: comparison of American Society of Therapeutic Radiology and Oncology Consensus or 1 ng/mL as endpoint.

Authors:  C A Perez; J M Michalski; M A Lockett
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-04-01       Impact factor: 7.038

7.  The efficacy and complications of salvage cryotherapy of the prostate.

Authors:  L L Pisters; A C von Eschenbach; S M Scott; D A Swanson; C P Dinney; C A Pettaway; R J Babaian
Journal:  J Urol       Date:  1997-03       Impact factor: 7.450

8.  Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.

Authors:  Michel Bolla; Laurence Collette; Léo Blank; Padraig Warde; Jean Bernard Dubois; René-Olivier Mirimanoff; Guy Storme; Jacques Bernier; Abraham Kuten; Cora Sternberg; Johan Mattelaer; José Lopez Torecilla; J Rafael Pfeffer; Carmel Lino Cutajar; Alfredo Zurlo; Marianne Pierart
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

9.  Salvage brachytherapy for localized prostate cancer after radiotherapy failure.

Authors:  G L Grado; J M Collins; J S Kriegshauser; C S Balch; M M Grado; G P Swanson; T R Larson; M M Wilkes; R J Navickis
Journal:  Urology       Date:  1999-01       Impact factor: 2.649

10.  Salvage radical prostatectomy in the management of locally recurrent prostate cancer after 125I implantation.

Authors:  P C Brenner; P Russo; D P Wood; M J Morse; S M Donat; W R Fair
Journal:  Br J Urol       Date:  1995-01
View more
  3 in total

Review 1.  Retreatment for prostate cancer with stereotactic body radiation therapy (SBRT): Feasible or foolhardy?

Authors:  Stefano Arcangeli; Linda Agolli; Vittorio Donato
Journal:  Rep Pract Oncol Radiother       Date:  2014-09-10

2.  [Tumour recurrence].

Authors:  O W Hakenberg; F Sedlmayer
Journal:  Urologe A       Date:  2010-02       Impact factor: 0.639

3.  [Appearance of carcinosarcoma after radiotherapy for local recurrence after radical prostatectomy. Case report and review of the literature].

Authors:  B Dallinger; E Würnschimmel
Journal:  Urologe A       Date:  2010-06       Impact factor: 0.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.